The emergence of the COVID-19 infectious disease pandemic has necessitated action to help ensure the unaccompanied alien children and program staff health and safety within the Unaccompanied Alien Children (UAC) Program.
The COVID-19 risk questionnaire asks participants whether or not they display COVID-19 symptoms, whether or not they have had close contact with individuals known to test positive for COVID-19, and whether or not they have travel history to areas of sustained transmission of COVID-19.
The information collected by conducting this survey at UAC programs will help ensure the health and safety of children in our care and our program staff by helping to identify and reduce potential exposure to COVID-19.
Due to the time sensitivity of collecting the information in the proposed COVID-19 risk questionnaire, we are requesting from OMB expedited review and approval through special processing. A request for review under normal procedures will be submitted within 180 days of the approval for this request.
Due to the time sensitivity of collecting the information in the proposed COVID-19 risk questionnaire, we are requesting from OMB expedited review and approval through special processing. A request for review under normal procedures will be submitted within 180 days of the approval for this request.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.